lobbying_activities: 1110169

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1110169	4a94d196-6327-4f15-8310-3b7cb185db8f	Q2	CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.	8511	ONYX PHARMACEUTICALS	2011	second_quarter	MED	Innovation in biotechnology; biosimilars; patient access to treatments; FDA accelerated approval process; orphan drugs for rare diseases.	HOUSE OF REPRESENTATIVES,SENATE	30000		0	0	2011-07-12T14:13:21.830000-04:00